Onto Health Raises $20M Series A to Expand AI-Powered Fertility and Longevity Care

Fertility has a way of getting boxed into timelines and transactions, packaged as inputs, outputs, and expectations that read clean on paper until real life refuses to cooperate and the system reveals just how much it was never designed to catch in the first place. ONTO Health just raised $20M in Series A funding from ARTIS and Humania, and if that registers as just another funding headline, it probably means you’re missing the signal sitting right underneath it.

Dr. Roohi Jeelani, MD, FACOG, Founder and CEO, didn’t build ONTO Health from theory but from lived experience, clinical reps, and direct exposure to the gaps that most models quietly ignore, recognizing that fertility isn’t an isolated event but a diagnostic window into the entire system, which ONTO translates into a physician-led model powered by intelligent diagnostics and clinical automation that treats reproductive health like the beginning of the story rather than something addressed after the fact.

Gary Kliegman, Co-Founder, brings the operational muscle to scale that vision without flattening it, because saying “patient-first” is easy but embedding it into workflows, automation, and real access is where most companies lose their edge and start sounding like everyone else.

ARTIS doesn’t chase noise and Humania doesn’t place bets without a map, so when both align on a $20M round it carries more than capital, signaling conviction with range as the U.S. footprint across Chicago and Colorado builds momentum while the GCC expansion through Humania’s network opens a broader stage where the same thesis travels well, positioning fertility as a leading indicator of long-term health across very different markets.

Zoom out and the pattern becomes clearer as the fertility market continues to scale while many players stay locked into reactive care, fragmented experiences, and systems that wait for problems instead of anticipating them, while ONTO Health connects the dots earlier and cleaner with a layer of intelligence that strengthens physicians instead of replacing them.

That’s where the separation happens, because tech in healthcare attracts attention but execution defines staying power, and ONTO isn’t selling a dashboard but building a continuum where diagnostics, automation, and longevity thinking are woven together so the patient experience feels intentional from start to finish.

For anyone building, investing, or rethinking care delivery, the takeaway sits in plain view as the companies that win won’t just treat conditions but reshape how they’re understood, and ONTO Health is placing its bet that fertility is where that shift begins, delivered with enough precision that the old model starts to feel outdated the moment you see what replaces it.